Viromed Medical AG - Asset Resilience Ratio

Latest as of September 2025: 2.49%

Viromed Medical AG (Q11) has an Asset Resilience Ratio of 2.49% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Viromed Medical AG to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€8.43 Million
≈ $9.86 Million USD Cash + Short-term Investments

Total Assets

€339.03 Million
≈ $396.36 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Viromed Medical AG's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Q11 total assets.

Liquid Assets Composition Over Time

This chart breaks down Viromed Medical AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Viromed Medical AG (Q11) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €8.43 Million 2.49%
Total Liquid Assets €8.43 Million 2.49%

Asset Resilience Insights

  • Limited Liquidity: Viromed Medical AG maintains only 2.49% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Viromed Medical AG Industry Peers by Asset Resilience Ratio

Compare Viromed Medical AG's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Agnico Eagle Mines Limited
TO:AEM
Gold 0.04%
Wheaton Precious Metals Corp
TO:WPM
Gold 1.69%
Northern Star Resources Limited
F:NS7
Gold 0.51%
Harmony Gold Mining Co. Ltd.
JSE:HAR
Gold 0.65%
Aris Mining Corporation
TO:ARIS
Gold 17.45%
Western Gold Co Ltd
SHG:601069
Gold 0.13%
Fortuna Silver Mines Inc
TO:FVI
Gold 9.98%
Sandstorm Gold Ltd N
TO:SSL
Gold 0.45%

Annual Asset Resilience Ratio for Viromed Medical AG (None–None)

The table below shows the annual Asset Resilience Ratio data for Viromed Medical AG.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points

About Viromed Medical AG

DU:Q11 Germany Gold
Market Cap
$3.85 Billion
€3.29 Billion EUR
Market Cap Rank
#12909 Global
#1364 in Germany
Share Price
€7.25
Change (1 day)
+0.69%
52-Week Range
€3.08 - €8.05
All Time High
€8.05
About

Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.